Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · IEX Real-Time Price · USD
2.490
-0.220 (-8.12%)
At close: Jul 2, 2024, 4:00 PM
2.470
-0.020 (-0.80%)
After-hours: Jul 2, 2024, 7:08 PM EDT
Anebulo Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for ANEB stock have an average target of 6.67, with a low estimate of 6.00 and a high estimate of 8.00. The average target predicts an increase of 167.87% from the current stock price of 2.49.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 3, 2023.
Analyst Ratings
The average analyst rating for ANEB stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Reiterates $8 | Buy | Reiterates | $8 | +221.29% | Oct 3, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +140.96% | Sep 25, 2023 |
| Maxim Group | Maxim Group | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +140.96% | Sep 21, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +140.96% | Sep 18, 2023 |
| Benchmark | Benchmark | Buy Reiterates $8 | Buy | Reiterates | $8 | +221.29% | May 18, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.46
from -0.47
EPS Next Year
-0.56
from -0.46
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | n/a | 28.7M | 82.7M | 134.2M |
| Avg | n/a | n/a | n/a | 13.9M | 80.3M | 130.3M |
| Low | n/a | n/a | n/a | n/a | 77.2M | 125.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | - | 493.8% | 67.0% |
| Avg | - | - | - | - | 476.8% | 62.2% |
| Low | - | - | - | - | 454.2% | 55.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -0.45 | -0.55 | -0.68 | -0.83 |
| Avg | -0.46 | -0.56 | -0.69 | -0.81 |
| Low | -0.47 | -0.57 | -0.70 | -0.77 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | - |
| Avg | - | - | - | - |
| Low | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.